https://doi.org/10.1074/jbc.m110.179127
L
Lucie Canaff
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
89
Papers
4.8K
Citations
40
h-index
64
i10-index
Lucie Canaff is an academic researcher from McGill University Health Centre. The author has contributed to research in topics: Parathyroid Disorders and Treatments & TGF-β signaling in diseases & Bone health and treatments. The author has an h-index of 40, co-authored 76 publications.
ORCID: 0000-0002-3311-6144Papers by this author
worksParathyroid Hormone-responsive Smad3-related Factor, Tmem119, Promotes Osteoblast Differentiation and Interacts with the Bone Morphogenetic Protein-Runx2 Pathway
2011 · Journal of Biological Chemistry · 92 citations
The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma
2015 · BMC Cancer · 33 citations
https://doi.org/10.1186/s12885-015-1177-1
Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes
2014 · Breast Cancer Research · 29 citations
https://doi.org/10.1186/s13058-014-0476-9
Impaired Transforming Growth Factor-β (TGF-β) Transcriptional Activity and Cell Proliferation Control of a Menin In-frame Deletion Mutant Associated with Multiple Endocrine Neoplasia Type 1 (MEN1)
2012 · Journal of Biological Chemistry · 28 citations
https://doi.org/10.1074/jbc.m112.341958
Translational readthrough therapy for ADPKD induces polycystin1 expression and partially rescues functional deficits in PKD1 mutant cells
2025 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-025-26775-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat